You haven't searched anything yet.
The Role
Ordaos is seeking a Principal Scientist of Drug Development to be a part of our ongoing mission to create bespoke mini-proteins to enable ground-breaking therapeutics. This new position will play a key role in the pursuit of our mission by leading the management of Ordaos internal asset programs as well as external drug development projects with Ordaos partners. This is a hybrid role in New York City (expected ~2-3 days a week in-office).
What You’ll Do
Requirements
Benefits
Ordaōs is a human-enabled, machine-driven drug design company. Our flagship solution, mini-PRO™, is a bespoke class of mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested in vitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our client’s stringent requirements at scale, including novelty and probability of clinical success. At Ordaōs, we create novel therapies that reduce patient suffering, improve health, and extend life.
Ordaos is a smoke-free and drug-free work environment.
Ordaos is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Ordaos will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Full Time
$137k-171k (estimate)
06/10/2024
06/26/2024
ordaos.bio
New York, NY
<25